| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a3651b83eebbb796dbfa98223fc062c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b28cc4dff22c39966f55eedc1106a4c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7e5eb93df8b1b710de28ccbb9cd06d9e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3158252756f1197b6a21c5d1c41825f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_113b7264e31d5a9872739a5dc68eb8ce |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C317-46 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-32 |
| filingDate |
2010-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63d7957291c49d6f924978643b6edadd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_565c427fba629f3edd5a5ac2dec61387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_504326d87462f9479bc30b56c6a15857
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d06a7be0b2e272c5b0a2beec1cd39665 |
| publicationDate |
2011-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011008543-A2 |
| titleOfInvention |
Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal |
| abstract |
Disclosed herein are novel antagonists of the androgen receptor and androgen receptor mutations associated with clinical failure of currently prescribed anti-androgens and use of said antagonists in the treatment of conditions associated with inappropriate activation of the androgen receptor. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014532686-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9895355-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022166781-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014036897-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9586947-B2 |
| priorityDate |
2009-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |